THC-H Explained: What It Feels Like and How It Differs from THC-P/HHC
Posted: 11/1/2025Sociedelic Sociedelic - Psychedelic Society Community and News THC-H (often written “THCH,” short for tetrahydrocannabihexol) pops up in product labels, but peer-reviewed research on its effects in humans is still very thin. Think of it as a rare THC-style molecule that likely occurs in tiny amounts in cannabis. Most of what we confidently know today comes from broader THC science, plus better-studied cousins […] The post THC-H Explained: What It Feels Like and How It Differs from THC-P/HHC appeared first on Sociedelic.
Edibles 101: Onset, Dosing, and Doing It Right
Posted: 11/1/2025Sociedelic Sociedelic - Psychedelic Society Community and News Edibles are the long-game of psychoactive formats: slower to arrive, richer in the middle, longer on the tail. Done well, they’re warm, steady, and kind to your lungs. Done carelessly, they’re “why is the ceiling breathing at my cousin’s birthday?” This guide treats you like an adult—clear, friendly, and based on how real people use […] The post Edibles 101: Onset, Dosing, and Doing It Right appeared first on Sociedelic.
Psychedelics May Rewire Memory Circuits Key to Mental Health
Posted: 10/27/2025New research suggests that psychedelic drugs may work by strengthening specific brain connections linked to memory and cognition. Scientists found that under psychedelic exposure, neurons in the claustrum—a region dense with psychedelic-sensitive receptors—intensified their communication with the anterior cingulate cortex, a region involved in mood and psychiatric disorders.
Kambo: Discoverings Its Origins
Posted: 10/22/2025Historical records from 1881–1936 in the Guyanas describe frog-based scarification rituals enhancing hunters’ skills. Linked to myths of human–frog transformations and shamanic power, these practices involved various frog species and substances. Such “batrachophilia” predates Amazonian kambo, suggesting the ritual’s possible origins in the Guyanas’ diverse Indigenous frog knowledge traditions.
The Psychedelic Syndicate: Part 4
Posted: 10/10/2025Part 4 of The Psychedelic Syndicate reveals PSFC’s strategy to manufacture spiritual and moral authority through academic capture — even as some members align with far-right ideologies that deepen the very crises psychedelics are meant to heal. The post The Psychedelic Syndicate: Part 4 appeared first on Psymposia.
The Psychedelic Syndicate: Part 3
Posted: 10/10/2025Part 3 of The Psychedelic Syndicate exposes how Silicon Valley's "move fast and break things" mentality infected psychedelic therapy, creating a culture where leaders rationalized patient harm as unavoidable for progress and ultimately embraced Trump administration officials who promised regulatory shortcuts. The post The Psychedelic Syndicate: Part 3 appeared first on Psymposia.
The Psychedelic Syndicate: Part 2
Posted: 10/10/2025Part 2 of The Psychedelic Syndicate exposes the compromised foundation of PSFC's influence network — from the abuse scandals that undermined their preferred therapy model, to undisclosed ties with the sole FDA advisory committee member who voted unequivocally for MDMA approval. The post The Psychedelic Syndicate: Part 2 appeared first on Psymposia.
The Psychedelic Syndicate: Part 1
Posted: 10/10/2025Part 1 of The Psychedelic Syndicate reveals how the Psychedelic Science Funders Collaborative (PSFC) — a wealthy network of Silicon Valley elites and Burning Man devotees — systematically captured the psychedelic movement by influencing MAPS, funding its subsidiary Lykos’ MDMA clinical trials, and promoting underground therapy through state legalization initiatives. The post The Psychedelic Syndicate: Part 1 appeared first on Psymposia.
The Psychedelic Syndicate: Part 1
Posted: 10/10/2025Part 1 of The Psychedelic Syndicate reveals how the Psychedelic Science Funders Collaborative (PSFC) — a wealthy network of Silicon Valley elites and Burning Man devotees — systematically captured the psychedelic movement by influencing MAPS, funding its subsidiary Lykos’ MDMA clinical trials, and promoting underground therapy through state legalization initiatives. The post The Psychedelic Syndicate: Part 1 appeared first on Psymposia.
Psilocybin therapy linked to reduced suicidal thoughts in people with psychiatric disorders
Posted: 10/9/2025Psilocybin therapy may reduce suicidal thoughts in people with mental health diagnoses, according to a new review in Therapeutic Advances in Psychopharmacology. The analysis combined results from clinical trials and found a modest but significant reduction in suicidal ideation.
Press Release – Chacruna Institute Opens Call for Speakers for Psychedelic Culture 2026
Posted: 10/8/2025The Chacruna Institute announces Psychedelic Culture 2026, a three-day conference on plant medicines and psychedelic science, April 17–19, 2026, at San Francisco’s Brava Theater. Speaker submissions are open until November 1, 2025. The event centers marginalized voices, intercultural dialogue, ethics, ecology, and spirituality, fostering inclusive, community-driven engagement in psychedelic studies.
Psilocybin-assisted group therapy may help reduce depression and burnout among healthcare workers
Posted: 10/4/2025In a pilot study, physicians and nurses who took part in mindfulness training combined with psilocybin therapy experienced greater reductions in depression symptoms than those who practiced mindfulness alone, offering preliminary evidence for a new approach to burnout treatment.
Psychedelic Humanities and Knowledge Making
Posted: 10/3/2025Chacruna is glad to invite you for a conversation exploring the intersections of humanities education and psychedelic therapy. Just as psychedelic-assisted treatments seek to transform consciousness and support healing, the study of literature, art, and culture has long worked to expand imagination, build empathy, and help us grapple with social and political realities.
Psilocybin Rewire Brain Circuits Tied to Pain and Mood
Posted: 10/2/2025New research shows that psilocybin, the active compound in psychedelic mushrooms, can reduce both chronic pain and pain-related depression by modulating brain circuits rather than acting at the site of injury. In mouse studies, a single dose provided pain relief and mood benefits lasting nearly two weeks by targeting the anterior cingulate cortex.
Where Harm is Structural, Care is Revolutionary
Posted: 10/2/2025Metzineres, based in El Raval, Barcelona, is a feminist, harm reduction–focused cooperative supporting women and gender-expansive people who use drugs. It challenges punitive, stigmatizing policies by fostering community, autonomy, and mutual care while addressing structural violence rooted in patriarchy, capitalism, and prohibition. Its model merges advocacy, empowerment, and collective care to transform exclusion.
Psychedelic Culture 2026
Posted: 9/26/2025The Psychedelic Culture Conference brings together leading voices from around the world to explore the intersections of psychedelics with culture, community, and social change.
Press Release – Enrolling Now: Foundations of Plant Medicine Facilitation, Integration, and Ethics
Posted: 9/26/2025The Chacruna Institute’s Foundations of Plant Medicine Facilitation, Integration, and Ethics course (October 20–December 22, 2025) offers 10 weeks of live, online training. Designed for facilitators, guides, chaplains, and clinicians, it emphasizes ethics, intercultural respect, trauma-informed care, Indigenous traditions, and integration practices. Faculty include anthropologists, psychologists, somatic educators, and harm reduction specialists.
Press Release – Ecology, Spirituality, and Psychedelics Workshop from Chacruna
Posted: 9/24/2025Chacruna Institute’s Ecology, Spirituality, and Psychedelics workshop (October 6, 2025) explores justice-based, ecologically conscious healing models. Led by Jamie Beachy, Stephanie Michael Stewart, and Bia Labate, it integrates reciprocity, Indigenous wisdom, and eco-chaplaincy with psychedelic therapy. Participants examine planetary health, ecological grief, nature-immersive practices, and human–Earth interconnectedness in psychedelic care.
Course: Psychedelics 101 for Community Religious Leaders
Posted: 9/23/2025A collaboration between the Chacruna Institute for Psychedelic Plant Medicines & Ligare, A Christian Psychedelic Society January 15–April 9, 2026 REGISTER HERE Do you wish you got into this event for […]
Press Release – Embrace Pleasure: How Psychedelics Can Heal Our Sexuality
Posted: 9/23/2025Based on Embrace Pleasure: How Psychedelics Can Heal Our Sexuality, Dee Dee Goldpaugh leads a 3-hour workshop exploring psychedelics, sexuality, trauma, desire, and empowerment. Participants will examine sexual healing, pleasure in discourse, policy impacts, integration tools, ethics, and community roles. The event targets therapists, educators, facilitators, and seekers of erotic liberation.
Press Release – Psychedelic Churches: From Legal Protections, to Ethics and Reciprocity
Posted: 9/22/2025The Chacruna Institute is hosting a virtual workshop, Psychedelic Churches: From Legal Protections to Ethics and Reciprocity, on October 1, 2025. Experts will discuss U.S. legal protections, key court cases, sincere religious belief, and ethical frameworks emphasizing reciprocity, cultural respect, and Indigenous perspectives. The event targets leaders, facilitators, advocates, and policy professionals.
Psychedelics Show Promise for Healing Concussions and Brain Injuries
Posted: 9/17/2025Traumatic brain injuries, including concussions, affect nearly 69 million people worldwide each year, yet treatments remain scarce. A new review highlights the potential of psychedelics such as psilocybin and 5-MeO-DMT to reduce harmful inflammation and enhance neuroplasticity after brain injury.
9/20 Magic Mushroom Day: The Movement That Won’t Stay Small
Posted: 9/16/2025Sociedelic Sociedelic - Psychedelic Society Community and News Cannabis has 4/20. LSD has Bicycle Day. Psilocybin mushrooms now have their own mark on the calendar: Magic Mushroom Day. What started quietly in small circles has become a cultural event that grows each year. From grassroots rallies and integration circles to memes, art, and academic conferences, this date now serves as a gathering point […] The post 9/20 Magic Mushroom Day: The Movement That Won’t Stay Small appeared first on Sociedelic.
Psychedelic Salvation: Inside the NFL's Radical Reckoning with Brain Trauma
Posted: 9/14/2025Forget the roar of the crowd. Forget the seismic crack of a perfect tackle. For a growing number of NFL veterans, the most haunting sound isn’t on the field it’s the silent, internal scream of a traumatized brain.
Psilocybin therapy linked to lasting depression remission five years later
Posted: 9/11/2025A treatment for depression involving just two doses of psilocybin may have effects that last for years. A new follow-up study found that two-thirds of participants were still in remission five years after their therapy, pointing to its potential durability.
Glow – The Magic Shroom Pill
Posted: 9/11/2025Sociedelic Sociedelic - Psychedelic Society Community and News There are times when mushrooms call us into the depths — heavy journeys filled with visions, questions, and echoes from the soul. And then there are nights when all we want is color, laughter, and that electric feeling of being alive. Glow, known as the Magic Shroom Pill, seems to lean toward the second path. […] The post Glow – The Magic Shroom Pill appeared first on Sociedelic.
Between East and West: Rediscovering Egypt’s Forgotten Psychedelic Psychiatry (1950s-1970s)
Posted: 9/8/2025A forgotten cache of LSD-25 in Cairo reveals Egypt’s overlooked role in early psychedelic psychiatry. Dr. Athanassios Kafkalides pioneered LSD-assisted therapy at the Greek Hospital (1960s–70s), integrating local culture and developing “autopsychognosia.” This discovery challenges Eurocentric histories, highlighting Egypt’s innovative contributions and offering lessons for culturally responsive psychedelic medicine today.